Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

被引：20
|
作者：
Hoelzer, S
Steiner, D
Bauer, R
Reiners, C
Farahati, J
Hundahl, SA
Dudeck, J
机构：
[1] Univ Giessen, Inst Med Informat, D-35392 Giessen, Germany
[2] Univ Giessen, Clin Nucl Med, D-35392 Giessen, Germany
[3] Univ Wurzburg, Clin & Policlin Nucl Med, D-97070 Wurzburg, Germany
[4] Amer Coll Surg, Commiss Canc, Chicago, IL USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2000年 / 27卷 / 10期
关键词：
differentiated thyroid cancer; guidelines; radioiodine; treatment;
D O I：
10.1007/s002590000333
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996, The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.
引用
收藏
页码：1465 / 1472
页数：8
相关论文
共 50 条
  • [41] Differentiated thyroid cancer: Lobectomy and radioiodine, a treatment suitable for all cases?
    Allan, E
    Owens, SE
    Waller, ML
    NUCLEAR MEDICINE COMMUNICATIONS, 1999, 20 (11) : 983 - 989
  • [42] Differentiated Thyroid Cancer - rhTSH Aided Radioiodine Treatment of Functional Metastases
    Hasse-Lazar, K.
    Roskosz, J.
    Handkiewicz-Junak, D.
    Szpak, S.
    Jarzab, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S197 - S197
  • [43] Radioiodine treatment of differentiated thyroid cancer despite history of 'iodine allergy'
    Puchalski, Adam R.
    Chopra, Inder J.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2014,
  • [44] HTG SERUM LEVELS IN THE RADIOIODINE TREATMENT OF DIFFERENTIATED THYROID-CANCER
    COTTINO, F
    FAVERO, A
    ROSSO, U
    ARIANO, M
    MERLO, M
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1983, 27 (02): : 93 - 93
  • [45] Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
    Esquerré-Lamare C.
    Isus F.
    Moinard N.
    Bujan L.
    Basic and Clinical Andrology, 2015, 25 (1)
  • [46] Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer
    Juweid, Malik E.
    Tulchinsky, Mark
    Mismar, Ayman
    Momani, Munther
    Zayed, Ayman A.
    Al Hawari, Hussam
    Albsoul, Nader
    Mottaghy, Felix M.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (09) : 2345 - 2354
  • [47] Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
    Herranz, Urbano Anido
    CANCER MEDICINE, 2022, 11 : 47 - 53
  • [48] Evolution of radioiodine treatment in differentiated thyroid carcinoma
    Tamayo-Alonso, Pilar
    Garcia-Talavera, Paloma
    Montes-Fuentes, Carlos
    Martin-Gomez, Esther
    Martin-Gomez, Enrique
    Diaz-Gonzalez, Luis
    REVISTA ORL, 2022, 13 (02) : 97 - 109
  • [49] Current management of pediatric thyroid disease and differentiated thyroid cancer
    Tracy, Elisabeth T.
    Roman, Sanziana A.
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (01) : 37 - 42
  • [50] Guidelines for radioiodine therapy of differentiated thyroid cancer
    M. Luster
    S. E. Clarke
    M. Dietlein
    M. Lassmann
    P. Lind
    W. J. G. Oyen
    J. Tennvall
    E. Bombardieri
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35
12345